Table 1.

Relationship Between Clinicopathological Parameters and miR-372 Expression in PCa

		miR-372 expression
Clinicopathologic parameters	Number of cases	Low (%)	High (%)	p
Age (years)
≤60	13	6 (46.2)	7 (53.8)	0.189
>60	7	5 (71.4)	2 (28.6)
Preoperative PSA (ng/mL)
<10	6	2 (33.3)	4 (66.7)	0.013
≥10	14	8 (57.1)	6 (42.9)
Gleason score
<7	11	6 (54.5)	5 (45.5)	0.234
≥7	9	4 (44.4)	5 (55.6)
Lymph node metastasis
No	7	3 (42.9)	4 (57.1)	0.003
Yes	13	9 (69.2)	4 (30.8)
Pathological stage
I + II	11	4 (36.4)	7 (63.6)	0.326
III+IV	9	5 (55.6)	4 (44.4)

PCa, prostate cancer; PSA, prostate-specific antigen.